ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
AB Corporate Bond ETF

AB Corporate Bond ETF (EYEG)

35.1095
0.0795
( 0.23% )
업데이트: 03:05:02

개인 투자자를 위한 전문가급 도구.

주요 통계 및 세부정보

가격
35.1095
매수가
35.08
매도가
35.13
거래량
13,451
35.03 일간 변동폭 35.14
34.52 52주 범위 37.24
market_cap
전일 종가
35.03
개장가
35.03
최근 거래 시간
1423
@
35.1095
마지막 거래 시간
03:05:02
재정 규모
US$ 471,523
VWAP
35.0548
평균 볼륨(3m)
3,148
발행 주식
7,689,000
배당수익률
-
주가수익률
-2.28
주당순이익(EPS)
-1.7
매출
-
순이익
-13.05M

AB Corporate Bond ETF 정보

The Fund is an actively-managed exchange-traded fund (ETF). The Fund pursues its objective by investing, under normal circumstances, at least 80% of its net assets, including any borrowings for investment purposes, in investment grade fixed-income securities of corporate issuers. Corporate issuers m... The Fund is an actively-managed exchange-traded fund (ETF). The Fund pursues its objective by investing, under normal circumstances, at least 80% of its net assets, including any borrowings for investment purposes, in investment grade fixed-income securities of corporate issuers. Corporate issuers may include corporate or other business entities in which a sovereign or governmental agency or entity may have, indirectly or directly, an interest, including a majority or greater ownership interest. The Funds investment objective is to maximize total return through current income and longterm capital appreciation. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
본부
Wilmington, Delaware, USA
설립됨
-
AB Corporate Bond ETF is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker EYEG. The last closing price for AB Corporate Bond ETF was US$35.03. Over the last year, AB Corporate Bond ETF shares have traded in a share price range of US$ 34.52 to US$ 37.24.

AB Corporate Bond ETF currently has 7,689,000 shares in issue. The market capitalisation of AB Corporate Bond ETF is US$269.35 million. AB Corporate Bond ETF has a price to earnings ratio (PE ratio) of -2.28.

EYEG 최신 뉴스

EyeGate Pharmaceuticals to Present at BIO CEO & Investor Conference in New York City

WALTHAM, Mass., Jan. 29, 2019 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”) today announced that the Company will attend and present at the 21st...

EyeGate Pharmaceuticals Announces Meeting Date with FDA

WALTHAM, Mass., Jan. 16, 2019 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”) today confirmed that it is scheduled to meet with the U.S. Food and...

EyeGate Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update

WALTHAM, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”) today announced financial results for the three-month period ended...

EyeGate Pharma Announces Positive Results in Second PRK Study

Data confirms results from earlier study WALTHAM, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) today announced top-line data from its study evaluating...

EyeGate Pharmaceuticals Signs Technology Transfer and License Agreement with SentrX Animal Care

WALTHAM, Mass., Oct. 02, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

EyeGate Pharmaceuticals Granted Additional 180 Days to Comply With Nasdaq Listing Rules

WALTHAM, Mass., Sept. 25, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

EyeGate Pharmaceuticals Completes Enrollment in Both PRK and PE Pilot Studies

WALTHAM, Mass., Sept. 24, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

EyeGate Announces Randomization of First Patients in Study for Punctate Epitheliopathies

WALTHAM, Mass., Sept. 04, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

EyeGate Announces Top-Line Results for Phase 3 Trial of EGP-437 in Anterior Uveitis

WALTHAM, Mass., Sept. 04, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.09950.28420451299635.0135.1634.9823835.06707983SP
4-0.4705-1.3223721191735.5835.5834.55524835.30937109SP
12-0.6805-1.9013690975135.7936.4434.555314835.95578324SP
26-0.5605-1.5713484721135.6737.2434.555184236.13058313SP
52-0.316-0.89201281562735.425537.2434.52114435.9282482SP
156-0.0905-0.25710227272735.237.2434.52106435.92580662SP
260-0.0905-0.25710227272735.237.2434.52106435.92580662SP

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
NVNINVNI Group Ltd
US$ 5.22
(250.34%)
281.18M
NEUPNeuphoria Therapeutics Inc
US$ 7.86
(125.21%)
18.64M
GOEVCanoo Inc
US$ 0.6106
(85.03%)
229.48M
PRFXPainReform Ltd
US$ 5.62
(76.18%)
12.54M
ELABPMGC Holdings Inc
US$ 3.02
(52.53%)
70.41M
NXTTNext Technology Holding Inc
US$ 1.58
(-48.03%)
677.31k
GODNUGolden Star Acquisition Corporation
US$ 7.40
(-42.46%)
1.29k
WHLRLWheeler Real Estate Investment Trust Inc
US$ 90.11
(-38.07%)
8
SGLYSingularity Future Technology Ltd
US$ 1.67
(-36.74%)
714.14k
DGNXDiginex Ltd
US$ 8.75
(-31.37%)
486.25k
ACONAclarion Inc
US$ 0.06005
(39.00%)
649.79M
NVNINVNI Group Ltd
US$ 5.22
(250.34%)
281.18M
GOEVCanoo Inc
US$ 0.6106
(85.03%)
229.48M
RIMEAlgorhythm Holdings Inc
US$ 0.038
(11.44%)
213.52M
RGTIRigetti Computing Inc
US$ 14.0988
(4.67%)
153.52M
BullNBear52 BullNBear52 1 분 전
This NFL kicker went viral for his routine before a game-winning kick in the playoffs. His OCD makes his job even tougher
https://www.cnn.com/2025/01/18/sport/zane-gonzalez-washington-commanders-ocd-kicker-spt-intl/index.html#:~:text=Esports-,This%20NFL%20kicker%20went%20viral%20for%20his%20r
packerfan9 packerfan9 1 분 전
Share buyback lol. At these levels no shareholders with shares have a gain. The only shares filling buys are more dilution. Wait and see. There will be no buyback. When they are selling shares what buyback? All lies. They make money now for 4 years selling shares. As sales are tiny even if the pr %
CBDL
m0n m0n 1 분 전
$TWOH is a SEC Filer & it's a penny stock.

Marshak bio has been updated within the amended 8k and I posted the DD on clearthink.capital.

https://clearthink.capital/about-us/


color="#000000" style="ca
TWOH
TheKid5 TheKid5 2 분 전
Dip. I got some. Now Rip!
MRES
PC retired PC retired 2 분 전
You witnessed a demo which was contrived to mislead you. Nobody is above being fooled, myself included, by a sufficiently devious demo.
ASRE
learningcurve2020 learningcurve2020 3 분 전
Since you mostly all ignore my postings this is a fresh thought for you.
NWBO
TightCoil TightCoil 3 분 전
Trump's Bessent To Explore GSE Restructuring Options (OTCMKTS:FNMAS)
https://seekingalpha.com/article/4751795-trumps-bessent-to-explore-gse-restructuring-options?source=generic_rss
FNMAS
TucsonPhil TucsonPhil 3 분 전
Companies will change their tactics and business models, in order to align with the direction of whichever party holds the majority.

The portfolios held by members of Congress have historically outperformed the best money managers on Wall Street. It would be foolish for big business t
LCID
jealmc79 jealmc79 3 분 전
" style="caret-color: rgb(29, 38, 46); color: rgba(29, 38, 46, 1); font-family: DMSans-Regular, sans-serif; font-size: 15px"They must periodically increase parental strain numbers, between production cycles."
style="caret-color: rgb(29, 38, 46); color: rgba(29, 38, 46, 1); font-family
KBLB
georgie18 georgie18 3 분 전
Nice trade...I am bidding the open gap from this morning...🥳
NVNI
SmoothTrader61 SmoothTrader61 3 분 전
https://www.otcmarkets.com/otcapi/company/financial-report/420618/content
BSTK
StayHumble StayHumble 3 분 전
💹Xplosive ShortFilm incoming💹$AMC Silver investments Golden💹 wow!!

'.....fire.....fire works.......believe it...."
https://cdn.vox-cdn.com/uploads/chorus_asset/file/8687957/tenor.gif
AMC
Monksdream Monksdream 3 분 전
FCNCA (own it) bought one of those failed SILICON VALLLEY banks new all time high

https://investorshub.advfn.com/uimage/uploads/2025/1/24/cqp[qIMG_4773.gif
FCNCA
AugustaFriends AugustaFriends 3 분 전
$RIME a 900% possibility to .34 cents TARGET !!! Just a RISKY Play possibility
RIME
trunkmonk trunkmonk 4 분 전
think of the phrase legend in your own mind, then look at a pic Carney, it fits.
FNMA
glenn1919 glenn1919 4 분 전
GNLX....DRMA.....IQ....MULN....................................https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=3&dy=0&id=p11960084343
DRMA GNLX MULN
StonkMaster StonkMaster 4 분 전
I don't think either is the case. The MHRA review isn't really taking that long when you compare it to the averages over the last year. 

As for the judge, who knows. New case law? I'm hoping we see the R&R after hours today.
NWBO
jxyzobrien jxyzobrien 4 분 전
sat shane class
i do not know
i am bullish till tariffs
forks doing their jobs
these are short term traders trading at mechanical levels
https://investorshub.advfn.com/uimage/uploads/2025/1/24/vtjfhes_24.png
JJZander JJZander 4 분 전
Looks good 
DGWR
art2426 art2426 4 분 전
>>>ENDV currently has a Market Cap of $218k.
ENDV
crazy horse 0 crazy horse 0 4 분 전
Top Trump Supporters Call For His Own Administration Official to Be Executed in Shocking Posts

In the tweet, Young claimed Birx should be charged “with the crimes she committed” with former Chief Medical Advisor Dr. Anthony Fauci .

https://www.msn.com/en-us/news/politi
Rubenstien Rubenstien 4 분 전
Todays massive volume says, big run coming! TKMO
TKMO
West2 West2 5 분 전
Check yahoo finance profile and you see for yourself 
DRGV
JOoa0ky JOoa0ky 5 분 전
HOLY HELL. Are y'all retreating to the Three Fifty Wall?
FNMA
PaladinKingdom14 PaladinKingdom14 5 분 전
ITS OVER
SHMP